Awake Prone Position in Hypoxemic Patients with Coronavirus Disease 19
- Funded by Canadian Institutes of Health Research (CIHR)
- Total publications:1 publications
Grant number: 172644
Grant search
Key facts
Disease
COVID-19Start & end year
20202020Known Financial Commitments (USD)
$816,903.75Funder
Canadian Institutes of Health Research (CIHR)Principal Investigator
PendingResearch Location
CanadaLead Research Institution
McMaster University MedicineResearch Priority Alignment
N/A
Research Category
Clinical characterisation and management
Research Subcategory
Clinical trials for disease management
Special Interest Tags
N/A
Study Type
Clinical
Clinical Trial Details
Unspecified
Broad Policy Alignment
Pending
Age Group
Unspecified
Vulnerable Population
Unspecified
Occupations of Interest
Unspecified
Abstract
Coronavirus disease (COVID-19) can cause low oxygen levels and life-threatening lung failure. Many COVID-19 patients will need treatment in the Intensive Care Unit (ICU) with life support and a breathing machine. A possible treatment that could stop patients in hospital from developing lung failure is prone positioning. Prone positioning is when a patient lays on their stomach and rests for several hours. The risks of prone positioning in COVID-19 are not known. We designed a clinical trial to test if prone positioning before patients need life support can prevent death or the need for a breathing machine. Patients with COVID-19 and low oxygen levels will be treated with either prone positioning or normal positioning. The clinical trial will be performed at 34 hospitals across Canada, Saudi Arabia, and Mexico. If prone positioning saves patients' lives or prevents the need for breathing machines, it will be used in hospitals across Canada and around the world.
Publicationslinked via Europe PMC
Last Updated:a day ago
View all publications at Europe PMC